8 results
CORRESP
REGN
Regeneron Pharmaceuticals, Inc.
7 Oct 22
Correspondence with SEC
12:00am
function, and the effect that this has on the board’s leadership structure.” The Proxy Statement currently includes a section titled “Board Oversight
DEFA14A
5i12arc1dp x5gbpul
26 Apr 19
Additional proxy soliciting materials
4:08pm
- Prev
- 1
- Next